Primary Site >> Colorectal Cancer
Gene >> NLK
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Genomic structure of the human NLK (nemo-like kinase) gene and analysis of its promoter region. PMID: 12039044 |
Ref: Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells. PMID: 12901858 |
Ref: Nemo-like kinase suppresses a wide range of transcription factors, including nuclear factor-kappaB. PMID: 14720327 |
Ref: Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma. PMID: 20512928 |
Ref: Zipper-interacting protein kinase (ZIPK) modulates canonical Wnt/beta-catenin signaling through interaction with Nemo-like kinase and T-cell factor 4 (NLK/TCF4). PMID: 21454679 |
Ref: NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer. PMID: 24972723 |
Ref: Nemolike kinase expression predicts poor survival in colorectal cancer. PMID: 25371216 Ref: Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine. PMID: 26084278 Ref: Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer. PMID: 26269673 |
Ref: Nemo-like kinase (NLK) primes colorectal cancer progression by releasing the E2F1 complex from HDAC1. PMID: 29803790 |